Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -22.030\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. Cc1cc[n+](CC(=O)c2ccc3c(c2)OCCO3)cc1.[Br-]
b. CC1=CCC(C(=O)O)C(C(=O)Nc2nc3ccc(S(C)(=O)=O)cc3s2)C1
c. O=C(c1cccnc1)C1Cc2ccccc2C1=O
d. Cl.N#Cc1ccc(OCC(=O)N2CCN(Cc3ccc4c(c3)OCO4)CC2)cc1
e. Cc1cc(C(=O)COC(=O)CN=C2NS(=O)(=O)c3ccccc32)c(C)n1CCc1ccc(Cl)cc1
Answer: d. Cl.N#Cc1ccc(OCC(=O)N2CCN(Cc3ccc4c(c3)OCO4)CC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cl.N#Cc1ccc(OCC(=O)N2CCN(Cc3ccc4c(c3)OCO4)CC2)cc1
Cl.N#Cc1ccc(OCC(=O)N2CCN(Cc3ccc4c(c3)OCO4)CC2)cc1
4-[2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-oxoethoxy]benzonitrile;hydrochloride